TOP 100 WEIGHT LOSS SITES
| |||
|
| |||
| |||
|
| |||
| Artery Plaque In Obese Kids' Similar To Middle-Aged Adults Study highlights: The plaque buildup in the neck arteries of obese children or those with high cholesterol is similar to levels in middle-aged adults. Using ultrasound images, researchers equated the "vascular age" to be 45 years old in these children. medicalnewstoday.com |
Kaiser Daily Health Policy Report Highlights Health Issues In State Of The State Addresses The following highlights health issues mentioned in governors' recent state of the state addresses.Rhode Island: In his Feb. 10 speech, Gov. Donald Carcieri (R) said that to survive the current economic downturn there are three steps that need to be taken including implementing the new Global Medicaid Waiver. medicalnewstoday.com |
Obesity Predicts Inadequate Bowel Prep At Colonoscopy Obesity is an independent predictor of inadequate bowel preparation at colonoscopy, and the presence of additional risk factors further increases the likelihood of a poorly cleansed colon, according to a new study in Clinical Gastroenterology and Hepatology, the official journal of the American Gastroenterological Association (AGA) Institute. Obesity has become an epidemic in the present era, both in the U.S. and in other developed nations. medicalnewstoday.com |
In Obese Sedentary Adolescents, Exercise Alone Shown To Improve Insulin Sensitivity A moderate aerobic exercise program, without weight loss, can improve insulin sensitivity in both lean and obese sedentary adolescents, according to a new study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM). Insulin is a hormone produced in the pancreas that permits glucose to enter cells to be used for energy or stored for future use by the body. medicalnewstoday.com |
Arena Pharmaceuticals Submits New Drug Application To FDA For Lorcaserin For Weight Management Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) announced that it has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for lorcaserin, Arena's internally discovered and developed drug candidate for weight management, including weight loss and maintenance of weight loss... medicalnewstoday.com |